Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis

Purpose: To identify the optimal initial 5 years of adjuvant endocrine therapy for hormone receptor-positive postmenopausal early breast cancer (EBC) patients. Methods: We conducted a systematic search of the PubMed, Web of Science, and EMBASE to obtain relevant studies published between January 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hao, Pei, Wendi, Zhong, Jianxin, Shao, Bin, Liu, Xiaoran, Liu, Yaxin, Zhang, Jiayang, Rugo, Hope S., Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198062/
https://www.ncbi.nlm.nih.gov/pubmed/35721183
http://dx.doi.org/10.3389/fphar.2022.886954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198062/
https://www.ncbi.nlm.nih.gov/pubmed/35721183
http://dx.doi.org/10.3389/fphar.2022.886954

Ejemplares similares